Skip to content

8-KAccepted Sep 25, 7:04 PM ET

Biotricity Inc. Director Resigns; Compensation Committee Updated

BTCYBIOTRICITY INC.

Accepted (ET)

7:04 PM

Sep 25, 2026

Filed

Sep 28, 2026

Documents

11

Size

194.7 KB

Summary

Biotricity Inc. Director Resigns; Compensation Committee Updated

Updated

What Happened

  • Biotricity Inc. (BTCY) filed an 8-K on Sept. 28, 2026 disclosing that director Jainal Bhuiyan resigned from the Board of Directors and from the Board’s Compensation Committee effective September 22, 2026. His resignation was not due to any disagreement with the company’s operations, policies or practices. Mr. Bhuiyan had served as a director since August 15, 2024.

Key Details

  • Resignation effective date: September 22, 2026.
  • Director resigned: Jainal Bhuiyan (served since Aug. 15, 2024); resignation not due to disagreement with the company.
  • Board size after resignation: three directors — Waqaas Al-Siddiq, David A. Rosa and Ronald McClurg.
  • Committee change: Ronald McClurg was appointed to the Compensation Committee (now David A. Rosa, chair, and Ronald McClurg). Audit and Nominating & Corporate Governance committee compositions remain unchanged.

Why It Matters

  • Director departures and committee membership changes affect board oversight and governance. Investors should note the board now has three members and a new Compensation Committee lineup, which could influence executive pay oversight and governance dynamics. The company has not decided whether to fill the open board seat or reduce the board’s size.

AI-written summary · check the filing